Originally published at www.seclive.com
Johnson & Johnson (NYSE:JNJ) reported revenues of $17.58B in its most recent financial results announcement for the third quarter fiscal 2013. The company earned $2.98B or $1.04 per share, up slightly from $2.97B and $1.05 per share a year ago. As a result of its strong performance, Johnson & Johnson raised its annual guidance from the previously established range of $5.40 to $5.47 to now between $5.44 and $5.49 per share. The company continues to trend upward thanks to its diverse portfolio of offerings, which has led to its success whereas other competitors that rely solely on a few key products are more susceptible to volatility. CEO Alex Gorsky commented that this quarter's results demonstrate the company's ability to achieve both near and long-term goals while continuing to grow the business.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.